Loading…

Human adipose-derived stem cells preconditioned with a novel herbal formulation Jing Shi attenuate doxorubicin-induced cardiac damage

Pathological cardiac hypertrophy is a considerable contributor to global disease burden. Chinese herbal medicine (CHM) has been used to treat cardiovascular diseases since antiquity. Enhancing stem cell-mediated recovery through CHM represents a promising approach for protection against doxorubicin...

Full description

Saved in:
Bibliographic Details
Published in:Aging (Albany, NY.) NY.), 2023-09, Vol.15 (17), p.9167-9181
Main Authors: Hsieh, Dennis Jine-Yuan, Tsai, Bruce Chi-Kang, Barik, Parthasarathi, Shibu, Marthandam Asokan, Kuo, Chia-Hua, Kuo, Wei-Wen, Lin, Pi-Yu, Shih, Cheng-Yen, Lin, Shinn-Zong, Ho, Tsung-Jung, Huang, Chih-Yang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-ef53e602683bd5fa9956920631170a6fba20e02154465a4e65c5f9ffc0ebc2a33
cites cdi_FETCH-LOGICAL-c365t-ef53e602683bd5fa9956920631170a6fba20e02154465a4e65c5f9ffc0ebc2a33
container_end_page 9181
container_issue 17
container_start_page 9167
container_title Aging (Albany, NY.)
container_volume 15
creator Hsieh, Dennis Jine-Yuan
Tsai, Bruce Chi-Kang
Barik, Parthasarathi
Shibu, Marthandam Asokan
Kuo, Chia-Hua
Kuo, Wei-Wen
Lin, Pi-Yu
Shih, Cheng-Yen
Lin, Shinn-Zong
Ho, Tsung-Jung
Huang, Chih-Yang
description Pathological cardiac hypertrophy is a considerable contributor to global disease burden. Chinese herbal medicine (CHM) has been used to treat cardiovascular diseases since antiquity. Enhancing stem cell-mediated recovery through CHM represents a promising approach for protection against doxorubicin (Dox)-induced cardiac hypertrophy. Herein, we investigated whether human adipose-derived stem cells (hADSCs) preconditioned with novel herbal formulation Jing Si (JS) improved protective ability of stem cells against doxorubicin-induced cardiac damage. The effect of JS on hADSC viability and migration capacity was determined via MTT and migration assays, respectively. Co-culture of hADSC or JS-preconditioned hADSCs with H9c2 cells was analyzed with immunoblot, flow cytometry, TUNEL staining, LC3B staining, F-actin staining, and MitoSOX staining. The in vivo study was performed M-mode echocardiography after the treatment of JS and JS-preconditioned hADSCs by using Sprague Dawley (SD) rats. Our results indicated that JS at doses below 100 μg/mL had less cytotoxicity in hADSC and JS-preconditioned hADSCs exhibited better migration. Our results also revealed that DOX enhanced apoptosis, cardiac hypertrophy, and mitochondrial reactive oxygen species in DOX-challenged H9c2 cells, while H9c2 cells co-cultured with JS-preconditioned hADSCs alleviated these effects. It also enhanced the expression of autophagy marker LC3B, mTOR and CHIP in DOX-challenged H9c2 cells after co-culture with JS-preconditioned hADSCs. In Dox-challenged rats, the ejection fraction and fractional shortening improved in DOX-challenged SD rats exposed to JS-preconditioned hADSCs. Taken together, our data indicate that JS-preconditioned stem cells exhibit a cardioprotective capacity both in vitro and in vivo, highlighting the value of this therapeutic approach for regenerative therapy.Pathological cardiac hypertrophy is a considerable contributor to global disease burden. Chinese herbal medicine (CHM) has been used to treat cardiovascular diseases since antiquity. Enhancing stem cell-mediated recovery through CHM represents a promising approach for protection against doxorubicin (Dox)-induced cardiac hypertrophy. Herein, we investigated whether human adipose-derived stem cells (hADSCs) preconditioned with novel herbal formulation Jing Si (JS) improved protective ability of stem cells against doxorubicin-induced cardiac damage. The effect of JS on hADSC viability and migration capacity was determine
doi_str_mv 10.18632/aging.205026
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10522400</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2865788607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-ef53e602683bd5fa9956920631170a6fba20e02154465a4e65c5f9ffc0ebc2a33</originalsourceid><addsrcrecordid>eNpVkUtP3DAUha2qqDzaZfdessng2LGTrCqESqFCYgGsrRv7esZVYk9tZ6A_oP-bwKCqrO6VztF3H4eQrzVb1Z0S_AzWPqxXnEnG1QdyVPeNrBrZ9R__6w_Jcc6_GFNSNuoTORRtyzredEfk79U8QaBg_TZmrCwmv0NLc8GJGhzHTLcJTQzWFx_Dojz6sqFAQ9zhSDeYBhipi2maR3hx0J_LNvRu4ymUgmGGgtTGp5jmwRsfKh_sbBaMgWQ9GGphgjV-JgcOxoxf3uoJebj8fn9xVd3c_ri-OL-pjFCyVOikQLXc2YnBSgd9L1XPmRJ13TJQbgDOkPFaNo2S0KCSRrreOcNwMByEOCHf9tztPExoDYaSYNTb5CdIf3QEr98rwW_0Ou50zSTnDWML4fSNkOLvGXPRk88vj4KAcc6ad0q2XadYu1irvdWkmHNC929OzfRrdvo1O73PTjwD_iuPxw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2865788607</pqid></control><display><type>article</type><title>Human adipose-derived stem cells preconditioned with a novel herbal formulation Jing Shi attenuate doxorubicin-induced cardiac damage</title><source>NCBI_PubMed Central(免费)</source><creator>Hsieh, Dennis Jine-Yuan ; Tsai, Bruce Chi-Kang ; Barik, Parthasarathi ; Shibu, Marthandam Asokan ; Kuo, Chia-Hua ; Kuo, Wei-Wen ; Lin, Pi-Yu ; Shih, Cheng-Yen ; Lin, Shinn-Zong ; Ho, Tsung-Jung ; Huang, Chih-Yang</creator><creatorcontrib>Hsieh, Dennis Jine-Yuan ; Tsai, Bruce Chi-Kang ; Barik, Parthasarathi ; Shibu, Marthandam Asokan ; Kuo, Chia-Hua ; Kuo, Wei-Wen ; Lin, Pi-Yu ; Shih, Cheng-Yen ; Lin, Shinn-Zong ; Ho, Tsung-Jung ; Huang, Chih-Yang</creatorcontrib><description>Pathological cardiac hypertrophy is a considerable contributor to global disease burden. Chinese herbal medicine (CHM) has been used to treat cardiovascular diseases since antiquity. Enhancing stem cell-mediated recovery through CHM represents a promising approach for protection against doxorubicin (Dox)-induced cardiac hypertrophy. Herein, we investigated whether human adipose-derived stem cells (hADSCs) preconditioned with novel herbal formulation Jing Si (JS) improved protective ability of stem cells against doxorubicin-induced cardiac damage. The effect of JS on hADSC viability and migration capacity was determined via MTT and migration assays, respectively. Co-culture of hADSC or JS-preconditioned hADSCs with H9c2 cells was analyzed with immunoblot, flow cytometry, TUNEL staining, LC3B staining, F-actin staining, and MitoSOX staining. The in vivo study was performed M-mode echocardiography after the treatment of JS and JS-preconditioned hADSCs by using Sprague Dawley (SD) rats. Our results indicated that JS at doses below 100 μg/mL had less cytotoxicity in hADSC and JS-preconditioned hADSCs exhibited better migration. Our results also revealed that DOX enhanced apoptosis, cardiac hypertrophy, and mitochondrial reactive oxygen species in DOX-challenged H9c2 cells, while H9c2 cells co-cultured with JS-preconditioned hADSCs alleviated these effects. It also enhanced the expression of autophagy marker LC3B, mTOR and CHIP in DOX-challenged H9c2 cells after co-culture with JS-preconditioned hADSCs. In Dox-challenged rats, the ejection fraction and fractional shortening improved in DOX-challenged SD rats exposed to JS-preconditioned hADSCs. Taken together, our data indicate that JS-preconditioned stem cells exhibit a cardioprotective capacity both in vitro and in vivo, highlighting the value of this therapeutic approach for regenerative therapy.Pathological cardiac hypertrophy is a considerable contributor to global disease burden. Chinese herbal medicine (CHM) has been used to treat cardiovascular diseases since antiquity. Enhancing stem cell-mediated recovery through CHM represents a promising approach for protection against doxorubicin (Dox)-induced cardiac hypertrophy. Herein, we investigated whether human adipose-derived stem cells (hADSCs) preconditioned with novel herbal formulation Jing Si (JS) improved protective ability of stem cells against doxorubicin-induced cardiac damage. The effect of JS on hADSC viability and migration capacity was determined via MTT and migration assays, respectively. Co-culture of hADSC or JS-preconditioned hADSCs with H9c2 cells was analyzed with immunoblot, flow cytometry, TUNEL staining, LC3B staining, F-actin staining, and MitoSOX staining. The in vivo study was performed M-mode echocardiography after the treatment of JS and JS-preconditioned hADSCs by using Sprague Dawley (SD) rats. Our results indicated that JS at doses below 100 μg/mL had less cytotoxicity in hADSC and JS-preconditioned hADSCs exhibited better migration. Our results also revealed that DOX enhanced apoptosis, cardiac hypertrophy, and mitochondrial reactive oxygen species in DOX-challenged H9c2 cells, while H9c2 cells co-cultured with JS-preconditioned hADSCs alleviated these effects. It also enhanced the expression of autophagy marker LC3B, mTOR and CHIP in DOX-challenged H9c2 cells after co-culture with JS-preconditioned hADSCs. In Dox-challenged rats, the ejection fraction and fractional shortening improved in DOX-challenged SD rats exposed to JS-preconditioned hADSCs. Taken together, our data indicate that JS-preconditioned stem cells exhibit a cardioprotective capacity both in vitro and in vivo, highlighting the value of this therapeutic approach for regenerative therapy.</description><identifier>ISSN: 1945-4589</identifier><identifier>EISSN: 1945-4589</identifier><identifier>DOI: 10.18632/aging.205026</identifier><identifier>PMID: 37708248</identifier><language>eng</language><publisher>Impact Journals</publisher><subject>Research Paper</subject><ispartof>Aging (Albany, NY.), 2023-09, Vol.15 (17), p.9167-9181</ispartof><rights>Copyright: © 2023 Hsieh et al.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-ef53e602683bd5fa9956920631170a6fba20e02154465a4e65c5f9ffc0ebc2a33</citedby><cites>FETCH-LOGICAL-c365t-ef53e602683bd5fa9956920631170a6fba20e02154465a4e65c5f9ffc0ebc2a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522400/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522400/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Hsieh, Dennis Jine-Yuan</creatorcontrib><creatorcontrib>Tsai, Bruce Chi-Kang</creatorcontrib><creatorcontrib>Barik, Parthasarathi</creatorcontrib><creatorcontrib>Shibu, Marthandam Asokan</creatorcontrib><creatorcontrib>Kuo, Chia-Hua</creatorcontrib><creatorcontrib>Kuo, Wei-Wen</creatorcontrib><creatorcontrib>Lin, Pi-Yu</creatorcontrib><creatorcontrib>Shih, Cheng-Yen</creatorcontrib><creatorcontrib>Lin, Shinn-Zong</creatorcontrib><creatorcontrib>Ho, Tsung-Jung</creatorcontrib><creatorcontrib>Huang, Chih-Yang</creatorcontrib><title>Human adipose-derived stem cells preconditioned with a novel herbal formulation Jing Shi attenuate doxorubicin-induced cardiac damage</title><title>Aging (Albany, NY.)</title><description>Pathological cardiac hypertrophy is a considerable contributor to global disease burden. Chinese herbal medicine (CHM) has been used to treat cardiovascular diseases since antiquity. Enhancing stem cell-mediated recovery through CHM represents a promising approach for protection against doxorubicin (Dox)-induced cardiac hypertrophy. Herein, we investigated whether human adipose-derived stem cells (hADSCs) preconditioned with novel herbal formulation Jing Si (JS) improved protective ability of stem cells against doxorubicin-induced cardiac damage. The effect of JS on hADSC viability and migration capacity was determined via MTT and migration assays, respectively. Co-culture of hADSC or JS-preconditioned hADSCs with H9c2 cells was analyzed with immunoblot, flow cytometry, TUNEL staining, LC3B staining, F-actin staining, and MitoSOX staining. The in vivo study was performed M-mode echocardiography after the treatment of JS and JS-preconditioned hADSCs by using Sprague Dawley (SD) rats. Our results indicated that JS at doses below 100 μg/mL had less cytotoxicity in hADSC and JS-preconditioned hADSCs exhibited better migration. Our results also revealed that DOX enhanced apoptosis, cardiac hypertrophy, and mitochondrial reactive oxygen species in DOX-challenged H9c2 cells, while H9c2 cells co-cultured with JS-preconditioned hADSCs alleviated these effects. It also enhanced the expression of autophagy marker LC3B, mTOR and CHIP in DOX-challenged H9c2 cells after co-culture with JS-preconditioned hADSCs. In Dox-challenged rats, the ejection fraction and fractional shortening improved in DOX-challenged SD rats exposed to JS-preconditioned hADSCs. Taken together, our data indicate that JS-preconditioned stem cells exhibit a cardioprotective capacity both in vitro and in vivo, highlighting the value of this therapeutic approach for regenerative therapy.Pathological cardiac hypertrophy is a considerable contributor to global disease burden. Chinese herbal medicine (CHM) has been used to treat cardiovascular diseases since antiquity. Enhancing stem cell-mediated recovery through CHM represents a promising approach for protection against doxorubicin (Dox)-induced cardiac hypertrophy. Herein, we investigated whether human adipose-derived stem cells (hADSCs) preconditioned with novel herbal formulation Jing Si (JS) improved protective ability of stem cells against doxorubicin-induced cardiac damage. The effect of JS on hADSC viability and migration capacity was determined via MTT and migration assays, respectively. Co-culture of hADSC or JS-preconditioned hADSCs with H9c2 cells was analyzed with immunoblot, flow cytometry, TUNEL staining, LC3B staining, F-actin staining, and MitoSOX staining. The in vivo study was performed M-mode echocardiography after the treatment of JS and JS-preconditioned hADSCs by using Sprague Dawley (SD) rats. Our results indicated that JS at doses below 100 μg/mL had less cytotoxicity in hADSC and JS-preconditioned hADSCs exhibited better migration. Our results also revealed that DOX enhanced apoptosis, cardiac hypertrophy, and mitochondrial reactive oxygen species in DOX-challenged H9c2 cells, while H9c2 cells co-cultured with JS-preconditioned hADSCs alleviated these effects. It also enhanced the expression of autophagy marker LC3B, mTOR and CHIP in DOX-challenged H9c2 cells after co-culture with JS-preconditioned hADSCs. In Dox-challenged rats, the ejection fraction and fractional shortening improved in DOX-challenged SD rats exposed to JS-preconditioned hADSCs. Taken together, our data indicate that JS-preconditioned stem cells exhibit a cardioprotective capacity both in vitro and in vivo, highlighting the value of this therapeutic approach for regenerative therapy.</description><subject>Research Paper</subject><issn>1945-4589</issn><issn>1945-4589</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkUtP3DAUha2qqDzaZfdessng2LGTrCqESqFCYgGsrRv7esZVYk9tZ6A_oP-bwKCqrO6VztF3H4eQrzVb1Z0S_AzWPqxXnEnG1QdyVPeNrBrZ9R__6w_Jcc6_GFNSNuoTORRtyzredEfk79U8QaBg_TZmrCwmv0NLc8GJGhzHTLcJTQzWFx_Dojz6sqFAQ9zhSDeYBhipi2maR3hx0J_LNvRu4ymUgmGGgtTGp5jmwRsfKh_sbBaMgWQ9GGphgjV-JgcOxoxf3uoJebj8fn9xVd3c_ri-OL-pjFCyVOikQLXc2YnBSgd9L1XPmRJ13TJQbgDOkPFaNo2S0KCSRrreOcNwMByEOCHf9tztPExoDYaSYNTb5CdIf3QEr98rwW_0Ou50zSTnDWML4fSNkOLvGXPRk88vj4KAcc6ad0q2XadYu1irvdWkmHNC929OzfRrdvo1O73PTjwD_iuPxw</recordid><startdate>20230915</startdate><enddate>20230915</enddate><creator>Hsieh, Dennis Jine-Yuan</creator><creator>Tsai, Bruce Chi-Kang</creator><creator>Barik, Parthasarathi</creator><creator>Shibu, Marthandam Asokan</creator><creator>Kuo, Chia-Hua</creator><creator>Kuo, Wei-Wen</creator><creator>Lin, Pi-Yu</creator><creator>Shih, Cheng-Yen</creator><creator>Lin, Shinn-Zong</creator><creator>Ho, Tsung-Jung</creator><creator>Huang, Chih-Yang</creator><general>Impact Journals</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230915</creationdate><title>Human adipose-derived stem cells preconditioned with a novel herbal formulation Jing Shi attenuate doxorubicin-induced cardiac damage</title><author>Hsieh, Dennis Jine-Yuan ; Tsai, Bruce Chi-Kang ; Barik, Parthasarathi ; Shibu, Marthandam Asokan ; Kuo, Chia-Hua ; Kuo, Wei-Wen ; Lin, Pi-Yu ; Shih, Cheng-Yen ; Lin, Shinn-Zong ; Ho, Tsung-Jung ; Huang, Chih-Yang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-ef53e602683bd5fa9956920631170a6fba20e02154465a4e65c5f9ffc0ebc2a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Hsieh, Dennis Jine-Yuan</creatorcontrib><creatorcontrib>Tsai, Bruce Chi-Kang</creatorcontrib><creatorcontrib>Barik, Parthasarathi</creatorcontrib><creatorcontrib>Shibu, Marthandam Asokan</creatorcontrib><creatorcontrib>Kuo, Chia-Hua</creatorcontrib><creatorcontrib>Kuo, Wei-Wen</creatorcontrib><creatorcontrib>Lin, Pi-Yu</creatorcontrib><creatorcontrib>Shih, Cheng-Yen</creatorcontrib><creatorcontrib>Lin, Shinn-Zong</creatorcontrib><creatorcontrib>Ho, Tsung-Jung</creatorcontrib><creatorcontrib>Huang, Chih-Yang</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Aging (Albany, NY.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hsieh, Dennis Jine-Yuan</au><au>Tsai, Bruce Chi-Kang</au><au>Barik, Parthasarathi</au><au>Shibu, Marthandam Asokan</au><au>Kuo, Chia-Hua</au><au>Kuo, Wei-Wen</au><au>Lin, Pi-Yu</au><au>Shih, Cheng-Yen</au><au>Lin, Shinn-Zong</au><au>Ho, Tsung-Jung</au><au>Huang, Chih-Yang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human adipose-derived stem cells preconditioned with a novel herbal formulation Jing Shi attenuate doxorubicin-induced cardiac damage</atitle><jtitle>Aging (Albany, NY.)</jtitle><date>2023-09-15</date><risdate>2023</risdate><volume>15</volume><issue>17</issue><spage>9167</spage><epage>9181</epage><pages>9167-9181</pages><issn>1945-4589</issn><eissn>1945-4589</eissn><abstract>Pathological cardiac hypertrophy is a considerable contributor to global disease burden. Chinese herbal medicine (CHM) has been used to treat cardiovascular diseases since antiquity. Enhancing stem cell-mediated recovery through CHM represents a promising approach for protection against doxorubicin (Dox)-induced cardiac hypertrophy. Herein, we investigated whether human adipose-derived stem cells (hADSCs) preconditioned with novel herbal formulation Jing Si (JS) improved protective ability of stem cells against doxorubicin-induced cardiac damage. The effect of JS on hADSC viability and migration capacity was determined via MTT and migration assays, respectively. Co-culture of hADSC or JS-preconditioned hADSCs with H9c2 cells was analyzed with immunoblot, flow cytometry, TUNEL staining, LC3B staining, F-actin staining, and MitoSOX staining. The in vivo study was performed M-mode echocardiography after the treatment of JS and JS-preconditioned hADSCs by using Sprague Dawley (SD) rats. Our results indicated that JS at doses below 100 μg/mL had less cytotoxicity in hADSC and JS-preconditioned hADSCs exhibited better migration. Our results also revealed that DOX enhanced apoptosis, cardiac hypertrophy, and mitochondrial reactive oxygen species in DOX-challenged H9c2 cells, while H9c2 cells co-cultured with JS-preconditioned hADSCs alleviated these effects. It also enhanced the expression of autophagy marker LC3B, mTOR and CHIP in DOX-challenged H9c2 cells after co-culture with JS-preconditioned hADSCs. In Dox-challenged rats, the ejection fraction and fractional shortening improved in DOX-challenged SD rats exposed to JS-preconditioned hADSCs. Taken together, our data indicate that JS-preconditioned stem cells exhibit a cardioprotective capacity both in vitro and in vivo, highlighting the value of this therapeutic approach for regenerative therapy.Pathological cardiac hypertrophy is a considerable contributor to global disease burden. Chinese herbal medicine (CHM) has been used to treat cardiovascular diseases since antiquity. Enhancing stem cell-mediated recovery through CHM represents a promising approach for protection against doxorubicin (Dox)-induced cardiac hypertrophy. Herein, we investigated whether human adipose-derived stem cells (hADSCs) preconditioned with novel herbal formulation Jing Si (JS) improved protective ability of stem cells against doxorubicin-induced cardiac damage. The effect of JS on hADSC viability and migration capacity was determined via MTT and migration assays, respectively. Co-culture of hADSC or JS-preconditioned hADSCs with H9c2 cells was analyzed with immunoblot, flow cytometry, TUNEL staining, LC3B staining, F-actin staining, and MitoSOX staining. The in vivo study was performed M-mode echocardiography after the treatment of JS and JS-preconditioned hADSCs by using Sprague Dawley (SD) rats. Our results indicated that JS at doses below 100 μg/mL had less cytotoxicity in hADSC and JS-preconditioned hADSCs exhibited better migration. Our results also revealed that DOX enhanced apoptosis, cardiac hypertrophy, and mitochondrial reactive oxygen species in DOX-challenged H9c2 cells, while H9c2 cells co-cultured with JS-preconditioned hADSCs alleviated these effects. It also enhanced the expression of autophagy marker LC3B, mTOR and CHIP in DOX-challenged H9c2 cells after co-culture with JS-preconditioned hADSCs. In Dox-challenged rats, the ejection fraction and fractional shortening improved in DOX-challenged SD rats exposed to JS-preconditioned hADSCs. Taken together, our data indicate that JS-preconditioned stem cells exhibit a cardioprotective capacity both in vitro and in vivo, highlighting the value of this therapeutic approach for regenerative therapy.</abstract><pub>Impact Journals</pub><pmid>37708248</pmid><doi>10.18632/aging.205026</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1945-4589
ispartof Aging (Albany, NY.), 2023-09, Vol.15 (17), p.9167-9181
issn 1945-4589
1945-4589
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10522400
source NCBI_PubMed Central(免费)
subjects Research Paper
title Human adipose-derived stem cells preconditioned with a novel herbal formulation Jing Shi attenuate doxorubicin-induced cardiac damage
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A33%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20adipose-derived%20stem%20cells%20preconditioned%20with%20a%20novel%20herbal%20formulation%20Jing%20Shi%20attenuate%20doxorubicin-induced%20cardiac%20damage&rft.jtitle=Aging%20(Albany,%20NY.)&rft.au=Hsieh,%20Dennis%20Jine-Yuan&rft.date=2023-09-15&rft.volume=15&rft.issue=17&rft.spage=9167&rft.epage=9181&rft.pages=9167-9181&rft.issn=1945-4589&rft.eissn=1945-4589&rft_id=info:doi/10.18632/aging.205026&rft_dat=%3Cproquest_pubme%3E2865788607%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-ef53e602683bd5fa9956920631170a6fba20e02154465a4e65c5f9ffc0ebc2a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2865788607&rft_id=info:pmid/37708248&rfr_iscdi=true